Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Tsui, H. Tsui, A. Akram, N. Haroon, R. Inman (2014)
The genetic basis of ankylosing spondylitis : new insights into disease pathogenesis
R. Peluso, S. Iervolino, M. Vitiello, V. Bruner, G. Lupoli, M. Minno (2015)
Extra-articular manifestations in psoriatic arthritis patientsClinical Rheumatology, 34
J. Taurog (2010)
The Role of HLA-B27 in SpondyloarthritisThe Journal of Rheumatology, 37
LM Rehaume, S Mondot (2014)
Aguirre de Carcer D, Velasco J, Benham H, et al. ZAP-70 genotype disrupts the relationship between microbiota and host leading to spondyloarthritis and ileitis. ArthritisRheumatol, 66
D. Kontoyiannis, M. Pasparakis, T. Pizarro, F. Cominelli, G. Kollias (1999)
Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.Immunity, 10 3
H. Benham, L. Rehaume, Sumaira Hasnain, J. Velasco, A. Baillet, M. Ruutu, K. Kikly, Ran Wang, Hsu‐Wen Tseng, G. Thomas, M. Brown, G. Strutton, M. McGuckin, Ranjeny Thomas (2014)
Interleukin‐23 Mediates the Intestinal Response to Microbial β‐1,3‐Glucan and the Development of Spondyloarthritis Pathology in SKG MiceArthritis & Rheumatology, 66
B. Meresse, N. Cerf‐Bensussan (2009)
Innate T cell responses in human gut.Seminars in immunology, 21 3
M. Coffre, M. Roumier, M. Rybczynska, E. Séchet, H. Law, L. Gossec, M. Dougados, E. Bianchi, L. Rogge (2013)
Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis.Arthritis and rheumatism, 65 6
M. Schoels, D. Heijde, F. Breedveld, G. Burmester, M. Dougados, P. Emery, G. Ferraccioli, C. Gabay, A. Gibofsky, J. Gómez-Reino, G. Jones, T. Kvien, Miho Murikama, N. Nishimoto, J. Smolen (2012)
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statementAnnals of the Rheumatic Diseases, 72
L. Saveanu, Oliver Carroll, V. Lindo, M. Val, Daniel López, Y. Lepelletier, F. Greer, L. Schomburg, D. Fruci, G. Niedermann, P. Endert (2005)
Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulumNature Immunology, 6
J. Taurog, J. Richardson, JoAnne Croft, W. Simmons, W. Simmons, Ming Zhou, Ming Zhou, J. Fernández-Sueiro, E. Balish, R. Hammer (1994)
The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic ratsThe Journal of Experimental Medicine, 180
A. Gottlieb, A. Menter, A. Mendelsohn, Yaung-Kaung Shen, Shu Li, C. Guzzo, S. Fretzin, R. Kunynetz, A. Kavanaugh (2009)
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trialThe Lancet, 373
Stuart Davidson, Yu Liu, P. Danoy, Xin Wu, G. Thomas, Lei Jiang, Linyun Sun, Niansong Wang, Jun Han, Huan-xing Han, P. Visscher, M. Brown, Huji Xu (2010)
Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han ChineseAnnals of the Rheumatic Diseases, 70
D. Poddubnyy, K. Hermann, J. Callhoff, J. Listing, J. Sieper (2014)
Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)Annals of the Rheumatic Diseases, 73
I. Song, F. Heldmann, M. Rudwaleit, H. Haibel, A. Weiß, J. Braun, J. Sieper (2011)
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot studyAnnals of the Rheumatic Diseases, 70
J. Taurog, M. Dorris, N. Satumtira, T. Tran, Rohit Sharma, R. Dressel, J. Brandt, H. Reichardt (2009)
Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8.Arthritis and rheumatism, 60 7
O. Martínez-González, J. Cantero-Hinojosa, P. Paule-Sastre, J. Gómez-Magán, D. Salvatierra-Rios (1994)
Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives.British journal of rheumatology, 33 7
F. Keyser, D. Baeten, F. Bosch, M. Vos, C. Cuvelier, H. Mielants, E. Veys (2002)
Gut inflammation and spondyloarthropathiesCurrent Rheumatology Reports, 4
P. Jacques, S. Lambrecht, E. Verheugen, E. Pauwels, G. Kollias, M. Armaka, M. Verhoye, A. Linden, R. Achten, R. Lories, D. Elewaut (2013)
Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cellsAnnals of the Rheumatic Diseases, 73
Hongbo Xu, Xiaohong Chen, Junwei Huang, Weiwei Deng, Q. Zhong, C. Yue, Pingzhang Wang, Zhigang Huang (2013)
Identification of GPR65, a novel regulator of matrix metalloproteinases using high through-put screening.Biochemical and biophysical research communications, 436 1
F. Lekpa, C. Poulain, D. Wendling, M. Soubrier, M. Bandt, J. Berthelot, P. Gaudin, E. Toussirot, P. Goupille, T. Pham, J. Sellam, R. Bruckert, M. Paul, V. Farrenq, P. Claudepierre (2012)
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational studyArthritis Research & Therapy, 14
H. Shen, J. Goodall, J. Gaston (2009)
Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis.Arthritis and rheumatism, 60 6
A. Cortes, J. Hadler, J. Pointon, P. Robinson, T. Karaderi, P. Leo, K. Cremin, Karena Pryce, J. Harris, Seunghun Lee, K. Joo, S. Shim, M. Weisman, Michael Ward, Xiaodong Zhou, H. Garchon, G. Chiocchia, J. Nossent, B. Lie, Ø. Førre, J. Tuomilehto, K. Laiho, Lei Jiang, Yu Liu, Xin Wu, L. Bradbury, D. Elewaut, R. Burgos-Vargas, S. Stebbings, L. Appleton, C. Farrah, Jonathan Lau, T. Kenna, N. Haroon, M. Ferreira, Jian Yang, J. Mulero, J. Fernández-Sueiro, M. González-Gay, C. López-Larrea, P. Deloukas, P. Donnelly, P. Bowness, K. Gafney, H. Gaston, D. Gladman, P. Rahman, W. Maksymowych, Huji Xu, J. Crusius, I. Horst-Bruinsma, C. Chou, R. Valle-Oñate, C. Romero-Sánchez, I. Hansen, F. Pimentel-Santos, R. Inman, V. Videm, Javier Martín, M. Breban, J. Reveille, David Evans, Tae-Hwan Kim, Bryan Wordsworth, M. Brown (2013)
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related lociNature Genetics, 45
T. Noordenbos, N. Yeremenko, I. Gofita, M. Sande, P. Tak, J. Cañete, D. Baeten (2012)
Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.Arthritis and rheumatism, 64 1
H. Mielants, E. Veys, C. Cuvelier, M. Devos, L. Botelberghe (1985)
HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis.The Journal of rheumatology, 12 2
A. Akram, Aifeng Lin, E. Gracey, C. Streutker, R. Inman (2014)
HLA-B27, but Not HLA-B7, Immunodominance to Influenza Is ERAP DependentThe Journal of Immunology, 192
J. Sherlock, B. Joyce-Shaikh, S. Turner, C. Chao, M. Sathe, J. Grein, D. Gorman, E. Bowman, T. Mcclanahan, J. Yearley, G. Eberl, C. Buckley, R. Kastelein, R. Pierce, D. Laface, D. Cua (2012)
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cellsNature Medicine, 18
Vanja Lazarevic, L. Glimcher, Graham Lord (2013)
T-bet: a bridge between innate and adaptive immunityNature Reviews Immunology, 13
A. Anandarajah, C. Ritchlin (2004)
Treatment update on spondyloarthropathyCurrent Opinion in Rheumatology, 17
C. Langrish, Brent McKenzie, N. Wilson, R. Malefyt, R. Kastelein, D. Cua (2004)
IL‐12 and IL‐23: master regulators of innate and adaptive immunityImmunological Reviews, 202
X. Baraliakos, N. Baerlecken, T. Witte, F. Heldmann, J. Braun (2013)
High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritisAnnals of the Rheumatic Diseases, 73
G. Galea, A. Sunters, L. Meakin, G. Zaman, T. Sugiyama, L. Lanyon, J. Price (2011)
Sost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4Febs Letters, 585
F. Ciccia, A. Accardo-Palumbo, R. Alessandro, A. Rizzo, Simona Principe, S. Peralta, F. Raiata, A. Giardina, G. Leo, G. Triolo (2012)
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis.Arthritis and rheumatism, 64 6
N. Sakaguchi, Takeshi Takahashi, H. Hata, T. Nomura, Tomoyuki Tagami, S. Yamazaki, T. Sakihama, T. Matsutani, I. Negishi, S. Nakatsuru, S. Sakaguchi (2003)
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in miceNature, 426
K. Sugimoto, A. Ogaẃa, E. Mizoguchi, Y. Shimomura, A. Andoh, A. Bhan, R. Blumberg, R. Xavier, A. Mizoguchi (2008)
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.The Journal of clinical investigation, 118 2
F. Tsui, H. Tsui, F. Heras, K. Pritzker, R. Inman (2013)
Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitisAnnals of the Rheumatic Diseases, 73
Caroline Diveu, M. McGeachy, D. Cua (2008)
Cytokines that regulate autoimmunity.Current opinion in immunology, 20 6
H. Hreggvidsdóttir, T. Noordenbos, D. Baeten (2014)
Inflammatory pathways in spondyloarthritis.Molecular immunology, 57 1
F. Ciccia, M. Bombardieri, A. Principato, A. Giardina, C. Tripodo, R. Porcasi, S. Peralta, V. Franco, E. Giardina, A. Craxì, C. Pitzalis, G. Triolo (2009)
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis.Arthritis and rheumatism, 60 4
J. Sherlock, C. Buckley, D. Cua (2014)
The critical role of interleukin-23 in spondyloarthropathy.Molecular immunology, 57 1
S. Visvanathan, C. Wagner, J. Marini, D. Baker, T. Gathany, J. Han, D. Heijde, J. Braun (2008)
Inflammatory biomarkers , disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab
A. Cauli, G. Dessole, M. Fiorillo, A. Vacca, Antonella Mameli, P. Bitti, Giuseppe Passiu, R. Sorrentino, A. Mathieu (2002)
Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease.Rheumatology, 41 12
Judith Smith, R. Colbert (2014)
Review: The Interleukin‐23/Interleukin‐17 Axis in Spondyloarthritis Pathogenesis: Th17 and BeyondArthritis & Rheumatology, 66
C. Jeanty, Adèle Sourisce, Aurélie Noteuil, N. Jah, Aurore Wielgosik, I. Fert, M. Breban, C. André (2014)
HLA–B27 Subtype Oligomerization and Intracellular Accumulation Patterns Correlate With Predisposition to SpondyloarthritisArthritis & Rheumatology, 66
M. Brown, L. Kennedy, A. Macgregor, C. Darke, E. Duncan, J. Shatford, A. Taylor, A. Calin, Paul Wordsworth (1997)
Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment.Arthritis and rheumatism, 40 10
Carlos Alvarez-Navarro, J. Castro (2014)
ERAP1 structure, function and pathogenetic role in ankylosing spondylitis and other MHC-associated diseases.Molecular immunology, 57 1
David Evans, C. Spencer, Jennifer Pointon, Z. Su, D. Harvey, G. Kochan, U. Oppermann, A. Dilthey, M. Pirinen, M. Stone, L. Appleton, L. Moutsianas, S. Leslie, T. Wordsworth, T. Kenna, T. Karaderi, G. Thomas, M. Ward, M. Weisman, C. Farrar, L. Bradbury, P. Danoy, R. Inman, W. Maksymowych, D. Gladman, P. Rahman, A. Morgan, H. Marzo-Ortega, P. Bowness, K. Gaffney, J. Gaston, Malcolm Smith, J. Bruges-Armas, A. Couto, R. Sorrentino, F. Paladini, M. Ferreira, Huji Xu, Yu Liu, Lei Jiang, C. López-Larrea, R. Díaz-Peña, A. López-Vázquez, T. Zayats, G. Band, C. Bellenguez, H. Blackburn, J. Blackwell, E. Bramon, S. Bumpstead, J. Casas, A. Corvin, N. Craddock, P. Deloukas, S. Dronov, A. Duncanson, S. Edkins, C. Freeman, M. Gillman, Emma Gray, R. Gwilliam, Naomi Hammond, S. Hunt, Janusz Jankowski, Alagurevathi Jayakumar, C. Langford, J. Liddle, H. Markus, C. Mathew, O. McCann, M. McCarthy, C. Palmer, L. Peltonen, R. Plomin, Simon Potter, A. Rautanen, Radhi Ravindrarajah, M. Ricketts, N. Samani, S. Sawcer, A. Strange, R. Trembath, A. Viswanathan, M. Waller, P. Weston, P. Whittaker, S. Widaa, N. Wood, G. McVean, J. Reveille, Bryan Wordsworth, M. Brown, P. Donnelly (2011)
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibilityNature Genetics, 43
M. Ruutu, G. Thomas, R. Steck, M. Degli-Esposti, M. Zinkernagel, Kylie Alexander, J. Velasco, G. Strutton, A. Tran, H. Benham, L. Rehaume, R. Wilson, K. Kikly, Julian Davies, A. Pettit, M. Brown, M. McGuckin, Ranjeny Thomas (2012)
β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice.Arthritis and rheumatism, 64 7
M. Rudwaleit, J. Listing, J. Brandt, Jürgen Braun, J. Sieper (2004)
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitisAnnals of the Rheumatic Diseases, 63
D. Baeten, X. Baraliakos, J. Braun, J. Sieper, P. Emery, D. Heijde, I. McInnes, J. Laar, R. Landewé, P. Wordsworth, J. Wollenhaupt, H. Kellner, J. Paramarta, Jiawei Wei, A. Brachat, S. Bek, D. Laurent, Yali Li, Ying Wang, A. Bertolino, S. Gsteiger, A. Wright, W. Hueber (2013)
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trialThe Lancet, 382
M. Corr (2014)
Wnt signaling in ankylosing spondylitisClinical Rheumatology, 33
E. Feldtkeller, M. Khan, D. Heijde, S. Linden, J. Braun (2003)
Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitisRheumatology International, 23
D. Daoussis, S. Liossis, E. Solomou, Anastasia Tsanaktsi, Konstadina Bounia, Maria Karampetsou, G. Yiannopoulos, A. Andonopoulos (2010)
Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.Arthritis and rheumatism, 62 1
J. Birtley, E. Saridakis, E. Stratikos, I. Mavridis (2012)
The crystal structure of human endoplasmic reticulum aminopeptidase 2 reveals the atomic basis for distinct roles in antigen processing.Biochemistry, 51 1
R. Colbert, T. Tran, G. Layh‐Schmitt (2014)
HLA-B27 misfolding and ankylosing spondylitis.Molecular immunology, 57 1
T. Kenna, Stuart Davidson, R. Duan, L. Bradbury, J. McFarlane, Malcolm Smith, H. Weedon, Shayna Street, Ranjeny Thomas, G. Thomas, M. Brown (2012)
Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.Arthritis and rheumatism, 64 5
C. Edwards, A. Bendele, L. Reznikov, G. Fantuzzi, E. Chlipala, Li Li, L. Moldawer, J. Mountz, Yi-Yang Li, C. Dinarello (2006)
Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha.Arthritis and rheumatism, 54 9
J. Rosenbaum, Phoebe Lin, M. Asquith, Mary-Ellen Costello, T. Kenna, M. Brown (2014)
Does the microbiome play a causal role in spondyloarthritis?Clinical Rheumatology, 33
Mary-Ellen Costello, D. Elewaut, T. Kenna, M. Brown (2013)
Microbes, the gut and ankylosing spondylitisArthritis Research & Therapy, 15
R. Lories, I. Derese, F. Luyten (2005)
Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis.The Journal of clinical investigation, 115 6
J. Reveille, M. Weisman (2013)
The Epidemiology of Back Pain, Axial Spondyloarthritis and HLA-B27 in the United StatesThe American Journal of the Medical Sciences, 345
S. Kwon, M. Lim, C. Suh, S. Park, Y. Hong, B. Yoon, Hyoun-Ah Kim, H. Choi, W. Park (2012)
Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapyRheumatology International, 32
H. Appel, R. Maier, P. Wu, R. Scheer, A. Hempfing, R. Kayser, A. Thiel, Andreas Radbruch, C. Loddenkemper, J. Sieper (2011)
Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune responseArthritis Research & Therapy, 13
C. Saad, A. Ribeiro, J. Moraes, L. Takayama, C. Gonçalves, M. Rodrigues, R. Oliveira, C. Silva, E. Bonfá, R. Pereira (2012)
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?Arthritis Research & Therapy, 14
I. Song, F. Heldmann, M. Rudwaleit, J. Listing, H. Appel, J. Braun, J. Sieper (2010)
Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.Arthritis and rheumatism, 62 5
I. York, Shi-Chung Chang, T. Šarić, Jennifer Keys, Janice Favreau, A. Goldberg, K. Rock (2002)
The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8–9 residuesNature Immunology, 3
J. Reveille (2014)
An update on the contribution of the MHC to as susceptibilityClinical Rheumatology, 33
C. Stolwijk, I. Essers, A. Tubergen, A. Boonen, M. Bazelier, M. Bruin, F. Vries (2014)
The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort studyAnnals of the Rheumatic Diseases, 74
F. Ciccia, A. Accardo-Palumbo, A. Rizzo, G. Guggino, S. Raimondo, A. Giardina, A. Cannizzaro, R. Colbert, R. Alessandro, G. Triolo (2013)
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammationAnnals of the Rheumatic Diseases, 73
P. Bowness, A. Ridley, J. Shaw, A. Chan, I. Wong-Baeza, M. Fleming, Fraser Cummings, A. McMichael, S. Kollnberger (2011)
Th17 Cells Expressing KIR3DL2+ and Responsive to HLA-B27 Homodimers Are Increased in Ankylosing SpondylitisThe Journal of Immunology, 186
Xiaolin Tu, Y. Rhee, K. Condon, Nicoletta Bivi, M. Allen, D. Dwyer, M. Stolina, C. Turner, A. Robling, L. Plotkin, T. Bellido (2012)
Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.Bone, 50 1
L. Rehaume, S. Mondot, D. Cárcer, J. Velasco, H. Benham, Sumaira Hasnain, J. Bowman, M. Ruutu, P. Hansbro, M. McGuckin, M. Morrison, Ranjeny Thomas (2014)
ZAP‐70 Genotype Disrupts the Relationship Between Microbiota and Host, Leading to Spondyloarthritis and Ileitis in SKG MiceArthritis & Rheumatology, 66
G. Sanchez, A. Jesus, R. Goldbach-Mansky (2013)
Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.Rheumatic diseases clinics of North America, 39 4
J. Reveille (2012)
Genetics of spondyloarthritis—beyond the MHCNature Reviews Rheumatology, 8
Noel García-Medel, A. Sanz-Bravo, Dung Nguyen, B. Galocha, Patricia Gómez-Molina, Adrián Martín-Esteban, Carlos Alvarez-Navarro, J. Castro (2012)
Functional Interaction of the Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 1 Polymorphism and HLA-B27 in Vivo*Molecular & Cellular Proteomics, 11
A. Boonen, J. Severens (2002)
Ankylosing spondylitis: what is the cost to society, and can it be reduced?Best practice & research. Clinical rheumatology, 16 4
S. Seregin, D. Rastall, Irini Evnouchidou, C. Aylsworth, Dionisia Quiroga, R. Kamal, S. Godbehere-Roosa, Christopher Blum, Ian York, E. Stratikos, A. Amalfitano (2013)
Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigensAutoimmunity, 46
M. Al-Mossawi, A. Ridley, Sarah Kiedel, P. Bowness (2013)
The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritisCurrent Opinion in Rheumatology, 25
Ritu Sarin, Xingxin Wu, C. Abraham (2011)
Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responsesProceedings of the National Academy of Sciences, 108
F. Ciccia, R. Alessandro, A. Rizzo, A. Accardo-Palumbo, S. Raimondo, F. Raiata, G. Guggino, A. Giardina, G. Leo, G. Sireci, G. Triolo (2014)
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis.Rheumatology, 53 1
P. Robinson, M. Brown (2014)
Genetics of ankylosing spondylitis.Molecular immunology, 57 1
H. Appel, R. Maier, J. Bleil, A. Hempfing, C. Loddenkemper, Uwe Schlichting, U. Syrbe, J. Sieper (2013)
In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis.Arthritis and rheumatism, 65 6
Ankylosing spondylitis is an insidiously progressive and debilitating form of arthritis involving the axial skeleton. The long delay in diagnosis and insufficient response to currently available therapeutics both advocate for a greater understanding of disease pathogenesis. Genome-wide association studies of this highly genetic disease have implicated specific immune pathways, including the interleukin (IL)-17/IL-23 pathway, control of nuclear factor kappa B (NF-κB) activation, amino acid trimming for major histocompatibility complex (MHC) antigen presentation, and other genes controlling CD8 and CD4 T cell subsets. The relevance of these pathways has borne out in animal and human subject studies, in particular, the response to novel therapeutic agents. Genetics and the findings of autoantibodies in ankylosing spondylitis revisit the question of autoimmune vs. autoinflammatory etiology. As environmental partners to genetics, recent attention has focused on the roles of microbiota and biomechanical stress in initiating and perpetuating inflammation. Herein, we review these current developments in the investigation of ankylosing spondylitis pathogenesis.
Current Allergy and Asthma Reports – Springer Journals
Published: Nov 22, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.